10x Genomics, Inc. (LON:0A88)

10x Genomics Statistics

Total Valuation

10x Genomics has a market cap or net worth of GBP 1.16 billion. The enterprise value is 895.14 million.

Market Cap	1.16B
Enterprise Value	895.14M

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	114.41M
Shares Outstanding	n/a
Shares Change (YoY)	+2.95%
Shares Change (QoQ)	+1.55%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	112.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.47
PB Ratio	2.06
P/TBV Ratio	2.11
P/FCF Ratio	27.97
P/OCF Ratio	23.76
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.50
EV / Sales	1.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	21.56

Financial Position

The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.11.

Current Ratio	5.84
Quick Ratio	5.05
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	1.53
Interest Coverage	-28,877.04

Financial Efficiency

Return on equity (ROE) is -11.30% and return on invested capital (ROIC) is -10.79%.

Return on Equity (ROE)	-11.30%
Return on Assets (ROA)	-9.45%
Return on Invested Capital (ROIC)	-10.79%
Return on Capital Employed (ROCE)	-16.64%
Revenue Per Employee	360,181
Profits Per Employee	-47,282
Employee Count	1,306
Asset Turnover	0.67
Inventory Turnover	2.50

Taxes

In the past 12 months, 10x Genomics has paid 3.85 million in taxes.

Income Tax	3.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.34%
50-Day Moving Average	13.18
200-Day Moving Average	12.02
Relative Strength Index (RSI)	43.12
Average Volume (20 Days)	7,733

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.16

Income Statement

In the last 12 months, 10x Genomics had revenue of GBP 470.40 million and -61.75 million in losses. Loss per share was -0.50.

Revenue	470.40M
Gross Profit	327.20M
Operating Income	-105.40M
Pretax Income	-57.90M
Net Income	-61.75M
EBITDA	-80.91M
EBIT	-105.40M
Loss Per Share	-0.50

Balance Sheet

The company has 326.46 million in cash and 63.31 million in debt, giving a net cash position of 263.14 million.

Cash & Cash Equivalents	326.46M
Total Debt	63.31M
Net Cash	263.14M
Net Cash Per Share	n/a
Equity (Book Value)	564.42M
Book Value Per Share	4.54
Working Capital	396.66M

Cash Flow

In the last 12 months, operating cash flow was 48.87 million and capital expenditures -7.35 million, giving a free cash flow of 41.51 million.

Operating Cash Flow	48.87M
Capital Expenditures	-7.35M
Free Cash Flow	41.51M
FCF Per Share	n/a

Margins

Gross margin is 69.56%, with operating and profit margins of -22.41% and -13.13%.

Gross Margin	69.56%
Operating Margin	-22.41%
Pretax Margin	-12.31%
Profit Margin	-13.13%
EBITDA Margin	-17.20%
EBIT Margin	-22.41%
FCF Margin	8.83%

Dividends & Yields

10x Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.95%
Shareholder Yield	n/a
Earnings Yield	-5.32%
FCF Yield	3.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

10x Genomics has an Altman Z-Score of 3.88 and a Piotroski F-Score of 5.

Altman Z-Score	3.88
Piotroski F-Score	5